The findings revealed that DCLRE1B was substantially overexpressed in the majority of cancer types including PAAD, which was verified at the protein and mRNA levels using PCR, WB, and IHC analysis. This evidence concerns the gene DCLRE1B and pancreatic adenocarcinoma.